Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse AIDS vaccines topic

 

Articles

1-300 out of 427 article(s) nextnext page
Title Author Type Date Words
Breast milk antibodies help neutralize HIV. May 23, 2012 464
HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine. May 22, 2012 1174
NIH statement on HIV Vaccine Awareness Day - May 18, 2012. May 14, 2012 102
IAVI, GlycoMimetics, and Glycosensors and Diagnostics Collaborate to Develop Novel AIDS Vaccine Candidate. May 9, 2012 815
Attend BIO tech 2012 Conference to Grab the Latest Trends on "Vaccines", Whose Market is Greatly Expanding. - Asia's Largest Bio Event. Conference news Apr 10, 2012 796
Leading Global Health Expert Dr. Adel A.F. Mahmoud Joins IAVI Board of Directors. Apr 9, 2012 715
Possible clues found to why HIV vaccine showed modest protection. Apr 5, 2012 157
AIDS vaccine testing on humans. Apr 1, 2012 260
Bacterial polysaccharide could lead to HIV vaccine. Irving, Tyler Apr 1, 2012 409
Cuba: AIDS vaccine testing on humans? Apr 1, 2012 341
PX'Therapeutics Announces EuroNeut-41 Prophylactic HIV Vaccine Clinical Trial. Mar 12, 2012 329
Effective vaccine against HIV/AIDS comes closer to reality. Mar 8, 2012 487
Effective HIV vaccines come closer to reality. Jan 5, 2012 356
First Human Volunteer Immunized in Clinical Trial of Profectus BioSciences' Vesicular Stomatitis Virus-vectored HIV-1 Vaccine. Jan 4, 2012 879
Human Trials Initiated for New HIV Vaccine. Dec 21, 2011 723
Nearly 90 Medicines and Vaccines In Development for HIV/AIDS. Dec 1, 2011 565
Johnson & Johnson turns its back on poor people with HIV. Harvey, Nick Dec 1, 2011 483
Top 10 Myths About HIV Vaccine Research (Dec. 1 is World Aids Day). Nov 18, 2011 1487
Research and Markets: Competitor Analysis: HIV Vaccines. Nov 7, 2011 296
Mary Tydings, Managing Director at Russell Reynolds Associates, Joins IAVI Board. Nov 1, 2011 742
GeoVax Phase 2a Clinical Trial Completes Enrollment. Oct 3, 2011 1010
Altered HIV cuts its ability to suppress immune system. Sep 29, 2011 247
HIV VACCINE HOPE AFTER NEW TRIALS. Sep 29, 2011 198
GeoVax Labs' CSO and Chairman Receive Academic Honors. Sep 29, 2011 790
Inovio Pharmaceuticals Completes PENNVAX(TM)-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses. Sep 14, 2011 1735
Inovio Pharmaceuticals to Present at Scientific Conferences. Conference news Sep 7, 2011 1111
GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government. Sep 1, 2011 720
Novel antibodies capable of blocking HIV infection isolated. Aug 18, 2011 248
AIDS Researchers Isolate New Potent and Broadly Effective Antibodies Against HIV. Aug 17, 2011 1691
GeoVax Awarded $3.6 Million Grant by U.S. Government for its HIV/AIDS Vaccine Program. Aug 16, 2011 796
NIH-Led Team Maps Route for Eliciting HIV Neutralizing Antibodies. Brief article Aug 11, 2011 133
HIV vaccine a priority, even if partially effective. Smith, Jennie Aug 1, 2011 616
SEEK Announces Clinical Proof of Efficacy in HIV Vaccine Phase Ib/II Human Trial. Jul 18, 2011 1708
A new battlefront: . Thaler, Sebastian Jul 1, 2011 2364
ViroStatics CEO Franco Lori, MD to Present Novel Immune-based Technologies for HIV/AIDS and Chronic Diseases at the 2011 BIO International Conference. Conference news Jun 27, 2011 511
GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine. Jun 23, 2011 1046
Scientists Launch Vaccine Research Foundation. Jun 8, 2011 1986
Scientists Launch Vaccine Research Foundation. Jun 8, 2011 2027
Profectus BioSciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Immunogenicity of a Vesicular Stomatitis Virus-vectored HIV-1 Vaccine. Jun 1, 2011 741
Scientists envisage vaccines for malaria, TB, HIV/AIDS by 2020. May 26, 2011 453
The ACTG Immunizes First Subject in Clinical Trial of Profectus BioSciences' Therapeutic HIV DNA Vaccine. May 25, 2011 996
Study shows promise for preventive vaccine against HIV/AIDS. May 24, 2011 251
On HIV Vaccine Awareness Day AVAC Calls For Continued Commitment to HIV Vaccine Research. May 18, 2011 715
Article by GeoVax Labs CSO Featured in The Scientist. May 13, 2011 743
VACCINE TO 'WIPE OUT' AIDS VIRUS; Jab left no trace of HIV after 1 year. May 12, 2011 411
VACCINE TO 'WIPE OUT' AIDS VIRUS; Jab left no trace of HIV after 1 year. May 12, 2011 374
MONKEY VACCINE HOPE FOR HIV CURE; Sick animals recover. May 12, 2011 317
Hope for millions after new AIDS vaccine 'removed all traces of disease in monkeys'. May 12, 2011 410
National HIV Vaccine Awareness Day May 18, 2011. May 11, 2011 117
Consortium Awards $23.4 Million for Promising HIV/AIDS Preventive Vaccine Candidate Developed by Institute of Human Virology at the University of Maryland School of Medicine. May 5, 2011 1123
Expansion of HIV/AIDS Vaccine Program Announced by GeoVax Labs, Inc. Apr 11, 2011 1123
GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress. Apr 7, 2011 843
Promising target for AIDS vaccine identified. Apr 1, 2011 413
Criminalizing HIV transmission and exposure in Canada: a public health evaluation. Drummond, Sarah L. Mar 22, 2011 6608
THSTI,IAVI announce new HIV vaccine design program in India. Mar 5, 2011 503
HIV vaccine design program launched in India. Mar 4, 2011 476
GEOVAX LABS REPORTS A 2010 4TH QTR NET LOSS OF $478,784. Financial report Mar 1, 2011 1237
GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases. Feb 23, 2011 1257
GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine. Feb 9, 2011 1017
GeoVax Labs CSO Dr. Harriet L. Robinson to be Honored at 2011 Georgia Bio (GaBio) Community Awards Ceremony. Jan 20, 2011 1065
New findings bring scientists closer to an effective HIV vaccine. Jan 15, 2011 246
Inovio Pharmaceuticals' Novel DNA Vaccine for Clade C HIV Achieves Immune Responses and Protection in Non-Human Primates. Jan 10, 2011 1200
Profectus BioSciences Announces Initiation of Clinical Trial of IL-12 Enhanced Therapeutic HIV DNA Vaccine Delivered Using Electroporation. Jan 5, 2011 965
Profectus Biosciences' GENEVAX IL-12 Adjuvant Significantly Improves pDNA Vaccine Performance in Phase I Human Trial. Dec 14, 2010 1164
Genetic Immunity Presents the DermaPrep Transdermal Delivery System and DermaVir Nanomedicine-based Therapeutic Vaccine for HIV/AIDS at HIV DART 2010 Drug Development Conference. Conference news Dec 9, 2010 439
VIRxSYS Presents New Therapeutic Vaccine Data at HIV DART 2010. Dec 8, 2010 541
GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial. Dec 6, 2010 959
100 Medicines and Vaccines in Development for HIV/AIDS. Nov 30, 2010 908
Designing More Effective Anti-HIV Antibodies. Nov 19, 2010 1088
Inovio Pharmaceuticals' HIV DNA Vaccine Achieves Strong T-Cell Immune Responses in Phase I Human Trial. Nov 17, 2010 1610
Inovio Pharmaceuticals HIV Study Update to be Presented at HVTN Conference. Clinical report Nov 12, 2010 888
GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program. Nov 4, 2010 886
Article by GeoVax Labs CEO Featured in October 15 Issue of Genetic Engineering & Biotechnology News. Oct 18, 2010 823
GeoVax Labs Announces Issuance of 6th Patent. Oct 7, 2010 1036
Mack-Cali signs headquarters lease with international AIDS organization. Oct 6, 2010 171
GenVec Receives Second-Year Funding From SAIC for HIV and Influenza Vaccine Development. Oct 6, 2010 741
Profectus BioSciences, Inc. Receives $4.4M in Grants to Develop an HIV Prophylactic Vaccine. Oct 5, 2010 491
Altravax, Inc. Awarded $1.2 Million in Federal Funds for Vaccines for HIV/AIDS. Oct 5, 2010 415
VIRxSYS Corporation Demonstrates "Functional Cure" and Survival Benefit for the simian model of HIV in Preclinical Vaccine Study. Oct 1, 2010 530
GeoVax Presents at AIDS Vaccine 2010 Conference in Atlanta. Oct 1, 2010 1336
Mack-Cali Announces NYC Headquarters Lease With International AIDS Vaccine Organization. Sep 30, 2010 705
Novel discoveries offer new ways to design HIV vaccine. Sep 30, 2010 547
Inovio Pharmaceuticals' HIV DNA Vaccine/Electroporation Delivery Technology Selected for NIH-Sponsored U.S. Army Human Clinical Trial. Sep 28, 2010 1747
Biojector[R]2000 Utilized in a Human Clinical Trial of DNA-MVA HIV Vaccine. Sep 28, 2010 727
New approach to fight HIV could spur vaccine development. Sep 28, 2010 353
IAVI-Led Team Wins Major Grant to Study HIV-Neutralizing Antibodies. Sep 27, 2010 1150
GeoVax to Present at Aids Vaccine 2010 Conference in Atlanta. Conference news Sep 27, 2010 1342
Biomedical approaches to HIV prevention. Mayer, Kenneth H.; Skeer, Margie; Mimiaga, Matthew J. Report Sep 22, 2010 7385
Inovio Completes Enrollment of HIV Clinical Trial for DNA Vaccine Delivered Using Electroporation. Clinical report Sep 21, 2010 952
CytoGenix, Inc. Announces Expansion of Its Advisory Board. Sep 9, 2010 705
GeoVax Labs to Present at the Rodman & Renshaw 12th Annual Healthcare Conference. Conference news Sep 7, 2010 889
AVAC Calls for AIDS Vaccine Field to Implement New Scientific Strategic Plan Released by Global HIV Vaccine Enterprise. Sep 7, 2010 751
Senior Merck Executive to Head IAVI's AIDS Vaccine Design and Development Laboratory. Aug 10, 2010 842
Safety & immunogenicity of tgAAC09, a recombinant adeno-associated virus type 2 HIV-1 subtype C vaccine in India. Mehendale, Sanjay; Sahay, Seema; Thakar, Madhuri; Sahasrabuddhe, Sushant; Kakade, Meghana; Shete, As Report Aug 1, 2010 5157
Three antibodies shown to block HIV: find may suggest new, if challenging, path to AIDS vaccine. Seppa, Nathan Jul 31, 2010 488
GeoVax's Chief Scientific Officer Interviewed on HealthRadio.net. Jul 22, 2010 1181
Report Warns Flat Global Funding for HIV Prevention Research May Limit Ability of Researchers to Move Promising Approaches Forward. Report Jul 20, 2010 1337
Abzyme Research Foundation Announces Promising HIV Vaccine Candidate. Jul 20, 2010 864
Immunacia's Genetic Immunity Reports Phase II Data on DermaVir, a Therapeutic Vaccine for HIV/AIDS, During the XVIII International AIDS Conference: A 70% Viral Load Reduction Demonstrated in HIV Drug-naove Individuals. Conference news Jul 19, 2010 687
An AIDS vaccine may be one step closer after scientists found antibodies in the blood of a patient that kill more than 90% of HIV strains, according to a study in the journal Science. Jul 12, 2010 559
Immunacia's Genetic Immunity Presents DermaVir at the 7th International Conference on Nanosciences & Nanotechnologies - A Unique Nanomedicine for Therapeutic HIV Vaccine. Conference notes Jul 12, 2010 539
HIV antibody discovery small step toward vaccine. Jul 12, 2010 448
Scientists Find Promising Method to Prevent, Treat HIV Infection. Jul 10, 2010 863
Antibodies that prevent 90pct of HIV strains from infecting humans discovered. Jul 9, 2010 383
AIDS vaccine eyed from HIV antibodies. Jul 8, 2010 199
Margaret McGlynn, Former President of Global Vaccines at Merck, Joins IAVI Board. Jul 6, 2010 782
Historic HIV Vaccine Trial Involving GeoVax Vaccine Spotlighted in The Georgia Voice and The Body. Jul 2, 2010 971
ARCA LAUNCHES THERAPEUTIC TRIAL WITH GEOVAX VACCINE. Jun 29, 2010 806
Japan Contributes $10 Million for AIDS Vaccine Development. Jun 28, 2010 682
Immunity glitch keeps HIV at bay: discovery could be helpful in future vaccine development. Saey, Tina Hesman Brief article Jun 5, 2010 322
Inovio Pharmaceuticals to Present at Investor Conferences. Conference news Jun 2, 2010 605
ARCA Launches First Therapeutic Trial with GeoVax Vaccine. May 27, 2010 1248
GeoVax Labs Spotlighted on Inc. Magazine Website. May 20, 2010 915
GeoVax to Present at HIV/AIDS Vaccine Symposium at New York Academy of Sciences on May 19. May 17, 2010 945
Turning the Page in HIV Prevention Research: An AIDS Vaccine is Possible -- AVAC Examines The Way Forward. May 17, 2010 1245
IAVI Statement for World AIDS Vaccine Day. May 14, 2010 802
Genetic Immunity Develops Unique Nanomedicine Formulation for DermaVir Therapeutic Vaccine for HIV/AIDS. May 13, 2010 461
Statement of Anthony S. Fauci, M.D., Margaret I. Johnston, Ph.D., and Gary J. Nabel, M.D., Ph.D., National Institute of Allergy and Infectious Diseases, National Institutes of Health, on National HIV Vaccine Awareness Day, May 18, 2010. May 11, 2010 134
Insights into a gene that helps some people fight HIV may revive the quest for vaccines against the deadly virus behind AIDS, said researchers at Harvard University and the Massachusetts Institute of Technology. May 10, 2010 346
New Findings May Lead to Designing Effective AIDS Vaccine. May 7, 2010 1137
Europe plots new bid to solve HIV vaccine challenge. Nuthall, Keith May 1, 2010 122
Inovio Biomedical CEO to Present at 2010 BIO International Convention. Apr 30, 2010 945
GeoVax Labs to Attend BIO International Convention May 3-6, 2010 in Chicago at McCormick Place; Exhibiting at Booth 1631 in Georgia Pavilion. Apr 29, 2010 988
GeoVax Labs Issues Letter to Shareholders. Apr 27, 2010 1138
Closing keynote: globalization and the diplomacy of science. Makhema, Joseph Apr 1, 2010 2573
GeoVax Labs Granted Allowance By FDA to Start Phase 1 Clinical Trial For HIV/AIDS Therapeutic Vaccine. Mar 30, 2010 958
Slowing down immune system's 'brakes' could perk up HIV vaccines' efficacy. Mar 27, 2010 421
Clinical Trials for HIV Vaccines Now Using Social Media to Attract Trial Participants. Mar 26, 2010 768
Argos Therapeutics Presents New Phase 2a Data on the Impact of Arcelis[TM] HIV Program on Viral Genetic Diversity. Mar 25, 2010 620
Clinical Trials for HIV Vaccines Now Using Social Media to Attract Trial Participants. Mar 24, 2010 818
Genetic Immunity Presents DermaVir at DNA Vaccines 2010 Conference - Unique Nanomedicine Formulation and Topical Administration of an HIV/AIDS Therapeutic Vaccine. Conference news Mar 2, 2010 448
HIV immunology: what lessons can we learn from recent vaccine trials? Kelleher, Peter Report Mar 1, 2010 3244
Cyto Pulse, the Karolinska Institute and the Swedish Institute for Infectious Disease Control Receive Phase I Clinical Trial Approval from the Swedish Medical Products Agency to Evaluate an HIV Vaccine in Healthy Volunteers. Feb 22, 2010 420
David N. Cook joins IAVI as Chief Operating Officer. Feb 1, 2010 706
NewsRx Publishes Encyclopedia of Vaccines, 2009: An encyK Resource for Parents, Patients & Professionals. Jan 27, 2010 752
HIV prevention responsibilities in HIV vaccine trials: complexities facing South African researchers. Essack, Zaynab; Slack, Catherine; Koen, Jennifer; Gray, Glenda Jan 1, 2010 3332
Scientist of Indian origin says AIDS vaccine in a decade. Dec 29, 2009 503
Biological catch-22 prevents generation of HIV blocking antibodies. Dec 16, 2009 535
Rabies vaccine offers hope for AIDS vaccine. Dec 15, 2009 263
Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (La Voices). Newman, Peter A.; Lee, Sung-Jae; Duan, Naihua; Rudy, Ellen; Nakazono, Terry K.; Boscardin, John; Kak Survey Dec 1, 2009 4676
Phase I Study of Preventive HIV Vaccine Shows Improved Immune Responses When the Vaccine is Delivered by Electrical Impulses. Nov 30, 2009 1314
'Breakthrough' Thai HIV vaccine trial controversy. Bateman, Chris Clinical report Nov 1, 2009 1528
SA 'ideal site' to further Thai HIV vaccine research gains. Bateman, Chris Brief article Nov 1, 2009 204
AIDS slipping off international funding agenda--Piot. Bateman, Chris Brief article Nov 1, 2009 230
Argos Therapeutics Presents Positive Phase 2 Viral Load and Immune Response Data for Arcelis[TM] HIV Program at the AIDS Vaccine 2009 Conference. Conference news Oct 21, 2009 1053
IN BRIEF. Oct 21, 2009 744
Thai HIV Vaccine Hype: AHF Reiterates Calls for Independent Review of AIDS Vaccine Effort. Oct 20, 2009 294
Inovio Biomedical and Its Collaborators Present Research and Clinical Data at AIDS Vaccine 2009 Conference. Conference news Oct 20, 2009 1076
Two Leading Research Institutions Partner to Accelerate the Development of an AIDS Vaccine Candidate. Oct 16, 2009 702
Inovio Biomedical Announces Initiation of HIV Clinical Trial for DNA Vaccine Delivered Using Electroporation. Clinical report Oct 15, 2009 1326
Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine under Its "Fillanthropy[TM] Program". Oct 15, 2009 900
HIV vaccine regimen cuts infections by 31%. Sullivan, Michele G. Oct 15, 2009 553
Argos Therapeutics to Present Positive Immune Response and Viral Load Data for Arcelis[TM] HIV Program at the AIDS Vaccine 2009 Conference. Conference news Oct 13, 2009 369
Thai HIV Vaccine Hype Misrepresents Data; AHF Calls for Independent Review of AIDS Vaccine Effort. Oct 12, 2009 431
SAAVI HIV vaccine trials--one small step for humankind. Ncayiyana, Daniel J. Oct 1, 2009 777
Inovio Biomedical to Present at Vaccine 3rd Global Congress. Sep 28, 2009 757
Hopes for new Aids vaccine. Sep 27, 2009 280
Hopes for new Aids vaccine. Sep 26, 2009 280
Editorial: Fighting AIDS. Editorial Sep 26, 2009 532
New hope over Aids virus vaccine. Sep 25, 2009 214
Hopes for new Aids vaccine. Sep 25, 2009 280
School gets $24M; AIDS, diabetes study. Sep 25, 2009 369
END OF AIDS? Vaccine cuts infection by a THIRD. Sep 25, 2009 504
END OF AIDS? Vaccine cuts infection by a THIRD. Sep 25, 2009 516
END OF AIDS? New double vaccine cuts HIV infection by a THIRD. Sep 25, 2009 512
AIDS vaccine hope. Sep 25, 2009 275
HIV Vaccine Study First to Show Some Effectiveness in Preventing HIV. Sep 24, 2009 756
Prime-Boost Vaccine Study Shows Modest Effect in Preventing HIV. Clinical report Sep 24, 2009 779
HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study. Clinical report Sep 24, 2009 139
HIV vaccine trial stopped infection; researchers find. Brief article Sep 24, 2009 159
AIDS vaccine hailed as 'historic milestone'. Sep 24, 2009 311
Aids vaccine protects trial volunteers. Sep 24, 2009 147
Hopes for Aids vaccine. Sep 24, 2009 147
Hopes for new Aids vaccine. Sep 24, 2009 280
Vaccine trial raises Aids hopes. Sep 24, 2009 520
A world first: Vaccine helps prevent HIV infection. Sep 24, 2009 577
Breakthrough AIDS vaccine prevents infection. Sep 23, 2009 480
HIV vaccine comes closer to reality. Sep 22, 2009 360
2 new antibodies may pave way for powerful AIDS vaccine. Sep 4, 2009 553
IAVI: Two New Antibodies Found to Cripple HIV. Sep 3, 2009 2104
Predicting phenotype and emerging strains among Chlamydia trachomatis infections. Dean, Deborah; Bruno, William J.; Wan, Raymond; Gomes, Joao P.; Devignot, Stephanie; Mehari, Tigist; Sep 1, 2009 6253
Dianne Stewart, Formerly of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Joins IAVI as Vice President of Resource Development. Aug 19, 2009 599
Inovio Biomedical to Present at Novel Vaccines: Design & Development. Aug 12, 2009 685
New strategies proposed for AIDS vaccine research. Aug 8, 2009 465
AIDS vaccine funding down 10% in 2008. Alcorn, Keith Aug 1, 2009 603
College students who feel 'invincible' unlikely to get HIV vaccine. Jul 30, 2009 329
Abbott Laboratories Inc. Brief article Jul 13, 2009 240
ON THIS DAY. Jul 11, 2009 189
HIV-1 destroys immune response in the gut within days of infection. Jul 7, 2009 444
IAVI and Theraclone Expand HIV Antibody Discovery Collaboration. Jul 6, 2009 741
Letter from the co-executive director. Simmons, Paul Report Jun 22, 2009 365
Back to basics (but not too far back) with vaccine research: an interview with Anthony S. Fauci, MD. Mascolini, Mark Interview Jun 22, 2009 1419
Scientists devise new strategy to design antibody-based HIV vaccine. Jun 15, 2009 384
ImmunoVaccine Technologies Partners With FIT Biotech to Advance a Therapeutic HIV Vaccine. May 26, 2009 504
New approach may pave way for effective HIV vaccine. May 23, 2009 410
Biotech Leaders, Patient Advocates Highlight Cutting-Edge HIV/AIDS Therapies, Need for Next Generation Treatments. May 19, 2009 1006
New approach may pave way for effective HIV vaccine. May 18, 2009 410
New Advances on the Long Road to the Development of an AIDS Vaccine. May 15, 2009 720
Statement of Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, on HIV Vaccine Awareness Day, May 18, 2009. May 15, 2009 89
Leading Vaccine Discovery Expert Joins the International AIDS Vaccine Initiative (IAVI). May 5, 2009 779
GeoVax signs HIV/AIDS vaccine proposal with health and hospital system of Cook County, Illinois. Company overview May 1, 2009 880
Why decades-long AIDS vaccine search hasn't been fruitful. Apr 23, 2009 688
vital: Now Aids vaccine is closer. Mar 16, 2009 355
Natural antibodies may pave way for effective HIV vaccine. Mar 16, 2009 557
Scientists make breakthrough in developing AIDS vaccine. Mar 13, 2009 461
Scientists have found a new way to make the human immune system react instantly against foreign invaders, including cancer, instead of the weeks or months that vaccines now take. Report Mar 9, 2009 386
HIV rapidly adapts to counter immune attack-controlling human genes. Feb 26, 2009 393
Bioject Enters into a Collaborative Research Agreement with IAVI for the Delivery of an HIV Vaccine Candidate. Feb 24, 2009 654
VGX Pharmaceuticals Proprietary DNA Vaccines Delivered with Electroporation Achieve Immune Responses Superior to Recombinant Adenovirus Serotype 5 (Ad5) Vectors. Feb 18, 2009 600
Massachusetts General Hospital, the Massachusetts Institute of Technology and Harvard University formed an institute with a $100 million gift to find a vaccine against the AIDS virus. Brief article Feb 9, 2009 234
Standard & Poor's Initiates Factual Stock Report Coverage on GeoVax Labs, Inc. Feb 5, 2009 618
Omnia Biologics and Sumagen Announce Successful Manufacture of HIV/AIDS Vaccine Phase I Material. Feb 4, 2009 314
IAVI and Algonomics to Collaborate on HIV Protein Design Project. Jan 26, 2009 964
Profectus BioSciences Awarded $21.6 Million in NIH Contracts to Develop a HIV Preventative and a HIV Therapeutic Vaccine. Dec 8, 2008 584
ADDING MULTIMEDIA GeoVax Labs and VGX International Announce Agreement at the Las Vegas "International Society of DNA Vaccines" Conference. Conference notes Dec 8, 2008 961
HIV vaccine may be developed in five years, says Nobel Prize laureate. Dec 7, 2008 165
IAVI Launches Video Commitments Project on World AIDS Day 2008. Dec 1, 2008 590
Gilead Science Inc.'s. Brief article Nov 17, 2008 255
New York City's Mayor Bloomberg and Other Honorees Herald the Opening of the Only Laboratory Devoted Solely to AIDS Vaccine Design and Development. Company overview Nov 12, 2008 1309
Profectus BioSciences Executes an Assignment and License Agreement with Wyeth for Vaccines against HIV, HCV, HPV and HSV. Nov 10, 2008 351
Centre Hospitalier Universitaire Vaudois, Swiss Vaccine Research Institute and Institut Genetique Moleculaire Montpellier: Study Sheds Light on the Mechanisms of Increased Risk of HIV Infection in the Step HIV Vaccine Trial. Nov 3, 2008 659
Preliminary Phase I Safety Data for Preventive HIV Vaccine Delivered by Ichor's TriGrid to be Presented at AIDS Conference. Oct 17, 2008 1084
VGX Pharmaceuticals Presents Non-Human Primate Study Data at AIDS Vaccine 2008 Conference. Conference news Oct 15, 2008 596
Stakeholders regroup after failure of latest AIDS vaccine. London, Susan Oct 15, 2008 801
Philadelphia story: 93% finish HIV vaccine trial. London, Susan Oct 15, 2008 608
GenVec Receives Third-Year Funding from NIAID for HIV Vaccine Contract. Oct 2, 2008 512
VGX Pharmaceuticals Awarded $23.5 Million NIH Contract to Develop DNA-Based Preventive HIV Vaccine Delivered Via Electroporation. Oct 1, 2008 612
Researchers rebound from latest AIDS vaccine failure. London, Susan Oct 1, 2008 663
Gilead Sciences Inc. Brief article Sep 8, 2008 143
Maxygen Receives $3.4 Million Government Grant to Develop Vaccine Discovery Technology. Aug 27, 2008 1080
Inovio Biomedical Expands In Vivo Electroporation License with International AIDS Vaccine Initiative for HIV Vaccine Research. Aug 14, 2008 1080
AIDS may be curable, preventable by 2031, top Scientist says. Aug 11, 2008 443
Mexico City AIDS 2008: Luminaries Call For Ending AIDS through A Vaccine at Global Conference. Conference news Aug 7, 2008 1221
Resetting Expectations in the Search for an AIDS Vaccine. Aug 5, 2008 1316
Glaxo says therapeutic vaccines hold big promise. Aug 4, 2008 348
AIDS Vaccines: Where Do We Go From Here? Jul 28, 2008 412
GeoVax Partners with Vivalis for Use of Its Revolutionary EBx(R) Technology to Manufacture Its MVA HIV/AIDS Vaccine. Jul 22, 2008 1745
NIAID Will Not Move Forward With The Pave 100 HIV Vaccine Trial. Jul 17, 2008 144
Diagnostic HYBRIDS Receives Third Frontier Grant for Development of Assays to Monitor Drug Resistance and Vaccine Production. Jun 27, 2008 947
NIAID Creates HIV Vaccine Discovery Branch to Promote Synergy between Basic HIV Researchers and Vaccine Designers. Jun 25, 2008 116
A dose of reality: revisiting pharmaceutical manufacturer liability for an HIV vaccine. Eisele, Erik Volker Ernst Jun 22, 2008 14899
Search for an HIV Vaccine Continues Despite Setbacks. Jun 3, 2008 369
Preparedness for AIDS vaccine trials in India. Excler, Jean-Louis; Kochhar, Sonali; Kapoor, Sushma; Das, Sweta; Bahri, Jyoti; Ghosh, Meenakshi Datt Report Jun 1, 2008 5349
Bavarian Nordic Enters Clinical Trials With HIV Multiantigen Vaccine. May 27, 2008 417
Bavarian Nordic Enters Clinical Trials with HIV Multiantigen Vaccine. May 27, 2008 452
NIAID to Advance B-Cell Approach to HIV Vaccines. May 20, 2008 115
Statement of Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, on HIV Vaccine Awareness Day, May 18, 2008. May 16, 2008 112
Lack of circumcision tied to HIV vaccine failure. May 15, 2008 503
MEDICAL MEMOS. Apr 28, 2008 132
Scientific Consensus on AIDS Vaccine Prospect is Bleak, Poll Reveals. Apr 25, 2008 712
NanoViricides to Begin HIV Animal Trials. Mar 27, 2008 541
Teleconference: AHF to Call for Halt to HIV Vaccine Funding. Mar 24, 2008 294
HIV Vaccine Funding: 'Enough is Enough,' Says AHF in Baltimore Sun. Mar 23, 2008 1133
Participants in HIV vaccine trials may experience negative social effects. Hollander, D. Clinical report Mar 1, 2008 1056
Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program. Mar 1, 2008 497
Challenges for intellectual property management of HIV vaccine-related research and development. Knowles, Lori; Bubela, Tania Jan 1, 2008 15500
Challenges for intellectual property management of HIV vaccine-related research and development. Patten, San; Bubela, Tania; Knowles, Lori Jan 1, 2008 17818
Creation of the Swiss Institute for Vaccine Research in Lausanne, Switzerland. Dec 5, 2007 478
Inside the HIV fight: from vaccines to microbicides, from preexposure prophylaxis to circumcision, researchers are considering multiple options in the fight to prevent HIV. Tim Murphy talks to the players involved and gives us a progress report. Murphy, Tim Dec 4, 2007 2103
AIDS Vaccine Failures Highlight Need to Focus on Lifesaving Treatment, Says AHF. Nov 16, 2007 497
STEP Study Volunteers to be Informed Whether They Received Vaccine or Placebo. Nov 13, 2007 688
Data from STEP Study Presented at Open Scientific Session Confirm Merck's Investigational HIV Vaccine was not Effective. Nov 7, 2007 3273
Bavarian Nordic Vaccine Programs Progressing as Planned. Nov 6, 2007 1075
AIDS vaccine development: challenges and opportunities. Chen, Robert T. Nov 1, 2007 545
U.S. AWARDS $15 MIL TO GEOVAX HIV/AIDS VACCINE PROGRAM. Nov 1, 2007 521
Ichor Medical Systems' TriGrid Selected as Delivery Platform in Collaboration to Test Preventative HIV Vaccine. Oct 1, 2007 897
ENCOURAGING PHASE II DATA ON GENVEC HIV VACCINE. Oct 1, 2007 322
United States awards $15 million grant to GeoVax' HIV/AIDS vaccine program. Oct 1, 2007 504
DIGEST. Sep 27, 2007 176
Vaccination and Enrollment Are Discontinued in Phase II Trials of Merck's Investigational HIV Vaccine Candidate. Sep 21, 2007 1681
Bavarian Nordic Strengthens its Commercial Organisation and Updates on Pipeline Progress. Sep 19, 2007 944
Etubics Awarded Grant from the National Institute of Health for Continued Development of HIV Vaccine. Aug 23, 2007 641
Encouraging Phase II Data on HIV Vaccine Utilizing GenVec Technologies Presented at Seattle AIDS Conference. Conference news Aug 23, 2007 551
Etubics Reports Breakthrough Next Generation HIV Vaccine at AIDS Conference. Conference news Aug 21, 2007 863
Inovio Biomedical Establishes Agreements with National Cancer Institute and International Aids Vaccine Initiative to Conduct Research Using Inovio's DNA Delivery Technology. Jul 24, 2007 1323
AIDS initiative signs first lease at bioscience center. Jul 11, 2007 338
New data on Gardasil[R]. Heller, Marissa Brief article Jul 1, 2007 163
Roche recalls Viracept due to chemical impurity. Brief article Jul 1, 2007 193
First Ad35-Based HIV-1 Vaccine Enters Phase I Clinical Trial at the NIH. Jun 21, 2007 699
Spanish Government Contributes 1 Million Euro for AIDS Vaccine Development. Jun 14, 2007 718
Ethical-legal challenges in adolescent HIV vaccine trials. Slack, Catherine; Strode, Ann; Mamashela, Mothokoa Jun 1, 2007 1966
Adolescents and HIV vaccine trials. Gray, G.; de Bruyn, G. Report Jun 1, 2007 1849
Recruitment and sexual risk assessment of HIV-negative adolescents aged 14-17 years in preparation for HIV vaccine trials. Jaspan, Heather; Mark, Daniella; Myer, Landon; Flisher, Alan; Mathews, Catherine; Soka, Nosiphiwo; M Jun 1, 2007 823
U.S. Developments Enhance Bavarian Nordic's Strategic Position. May 2, 2007 1316
Prostitutes test AIDS vaccine. Apr 1, 2007 207
AIDS Vaccine Advocacy Coalition Calls for Strategic Leadership and Urgency in the Implementation of Male Circumcision for HIV Prevention. Mar 28, 2007 629
From the editor. Bekker, Linda-Gail Brief article Mar 22, 2007 322
Cerus Corporation Awarded Grants for Its Listeria-Based Vaccine Platforms. Mar 5, 2007 738
First large-scale HIV vaccine study starts in South Africa. Brief article Mar 1, 2007 241
Inovio Biomedical DNA Delivery Technology Presented by Wyeth Researcher at Vaccine Conference. Feb 16, 2007 700
AVAC Applauds Commencement of First HIV Vaccine Efficacy Trial in Africa. Feb 8, 2007 544
HIV controllers: an untapped source of clues to overcoming HIV infection. Walker, Bruce D. Jan 1, 2007 966
HIV vaccines: the future looks promising. Lewis, Dorothy E. Jan 1, 2007 1849
CytoGenix synDNA(TM) HIV Vaccine Shows Robust Cellular Immune Response in Monkeys. Dec 12, 2006 599
CytoGenix synDNA(TM) HIV Vaccine Shows Robust Cellular Immune Response in Monkeys. Dec 11, 2006 599
European Governments Invest an Additional euro 26 Million in AIDS Vaccine Development. Dec 1, 2006 679
The European and Developing Countries Clinical Trials Partnership (EDCTP) and the Bill & Melinda Gates Foundation Launch a 20 M Euro Call to Develop HIV Vaccine Trial Capacity in Africa. Nov 30, 2006 427
GenVec HIV Vaccine Program to Receive Additional Funding. Oct 10, 2006 577
GenVec Announces New $52 Million Contract with NIH/NIAID Vaccine Research Center to Support HIV Vaccine Production. Oct 5, 2006 585
GENVAC VACCINE ENTERS HIV HUMAN THERAPEUTIC CLINICAL TRIALS. Oct 1, 2006 438

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles